Previous studies have documented discordant cellular and humoral immune responses to subjects exposed to HIV-1, and that the nature of such responses may determine susceptibility and resistance to disease. We determined whether there is a spectrum of cellular versus humoral immunodominant responses to cytomegalovirus (CMV) infection. Blood samples from 50 healthy blood donors were tested for anti-CMV IgG antibodies and for proliferative responses of peripheral blood mononuclear cells (PBMC) to CMV antigens. Four patterns of immune responses to CMV were found: no detectable response (30%, Ab -/Tc -), anti-CMV IgG only (28%, Ab ⍣ /Tc -), both anti-CMV IgG and T lymphocyte proliferation to CMV antigens (18%, Ab ⍣ /Tc ⍣ ), and, interestingly, T lymphocyte proliferation to CMV only (24%, Ab -/Tc ⍣ ). To determine whether these immunodominant phenotypes correlate with the ability of PBMC to secrete IL-2 and IFN-γ in response to CMV antigens, we found that a greater percentage of individuals with a T cell proliferative response to CMV antigens (Ab -/Tc ⍣ and Ab ⍣ /Tc ⍣ ) responded with increased IL-2 (P ⍧ 0.001) and IFN-γ levels (P ⍧ 0.002), compared to those without a proliferative response (Ab -/Tc -and Ab ⍣ /Tc -). Our data therefore demonstrate that different individuals exhibit different immunodominant patterns of response to CMV. In particular, some individuals who are exposed to CMV fail to develop an antibody response but do develop cellular immunity. Whether these different patterns predict susceptibility or resistance to CMV-induced disease remains to be determined.
Introduction
The type of immune response (cellular or humoral) to an Human cytomegalovirus (CMV), like other Herpesviruses, persists in the infected host for life. Under certain circuminfection can influence whether the host will succeed in eliminating the pathogen, or will develop persistent infection stances, it can be reactivated to cause clinically important disease. Most known CMV-related diseases occur in immunewith the establishment of chronic or recurrent disease. Although the humoral arm of the immune system is important compromised patients, such as patients following organ transplantation (10) and AIDS patients (11) . Clinically relevant mainly for prevention of infection or spread of infection via extracellular compartments, if pathogens gain entry to CMV-induced disease, however, may not be limited to immune-compromised subjects, as an increasing body of intracellular sites the cell-mediated immune response becomes essential to pathogen elimination or control. Data data suggests that CMV may contribute to the development of vascular diseases such as re-stenosis following coronary compatible with this concept come from studies of infectious diseases such as HIV-1 (1-5), chronic hepatitis B (6) and angioplasty (12, 13) and atherosclerosis (14) (15) (16) (17) . Previous studies have demonstrated that the cell-mediated leishmaniasis (7-9).
immune response to CMV is of critical importance in eliminatSamples for anti-CMV IgG antibodies were tested in triplicate and in two separate experiments. ing the virus from the host in a murine model (18) . Although studies in immunocompetent humans are not available, it was CMV antigen preparations found that patients with AIDS who had a cellular-mediated
The Towne strain of human CMV was obtained from ATCC immune response to CMV were relatively resistant to CMV-(Rockville, MD) and grown in human fibroblasts, HEL299 induced retinitis, while patients lacking this response were (ATCC), for preparation of the viral antigens. Growth media susceptible (11) . We hypothesized that certain immunoconsisted of minimum essential medium (Gibco) supplecompetent individuals infected with CMV lack an efficient cellmented with 2% fetal bovine serum and antibiotics. Virus titer mediated immune-surveillance system targeted to CMV and was measured on HEL299 cells. The protocols for CMV thereby have an impaired capacity to eliminate the virus or antigen preparations have been published (11, 20, 21) . Briefly, to prevent its reactivation from latency.
CMV antigens were prepared with (i) heat-inactivated CMV As a first step in testing the validity of this hypothesis, we
(1 h at 56°C) that was obtained from supernatants of CMVdetermined whether a spectrum of humoral versus cellular infected fibroblasts (final concentration of virus was 10 5 p.f.u. responses to CMV infection exists in immunocompetent indibefore inactivation), (ii) cell lysates of CMV-infected fibroblasts viduals, and whether discordant responses of these two arms by repeated freezing and thawing, and (iii) 0.08% glutaralof the immune system can occur in the same individual, as dehyde-fixed, CMV-infected fibroblast cells. Both cell lysates has been demonstrated in the response to HIV-1S (1-5) and and fixed cells were prepared from 2ϫ10 6 /ml cells by infecting more recently to hepatitis C virus (19) . The demonstration a 90% confluent monolayer of human fibroblasts with CMV at that such disparities in the immune response to CMV do in a m.o.i. of 10. Cells were collected by centrifugation when fact exist would be of importance as it would raise new they showed 50% cytopathic effect. The large stocks were paradigms for understanding individual variations in the susaliquoted and stored at -70°C. Controls for the CMV antigens ceptibility versus resistance to chronic disease related to were obtained from non-infected fibroblasts (mock-infected CMV and perhaps even more generically to chronic disease cells), prepared exactly as described for CMV-infected cells. that may be induced by a broad array of pathogens.
T lymphocyte proliferation T lymphocyte proliferative responses were performed in 96-Methods well flat-bottom plates (Costar, Cambridge, MA). An aliquot of 100 µl of PBMC (3ϫ10 6 /ml) was added to each well. PBMC
Blood donors
were cultured at 37°C with 5% CO 2 in RPMI 1640 (Gibco) Fifty healthy individuals were entered into this study. They containing 5% human AB serum, 2 mM L-glutamine, 100 U/ volunteered under a National Heart, Lung and Blood Institute ml penicillin, 100 µg/ml streptomycin and HEPES buffer, with IRB-approved protocol to donate blood to the Transfusion or without antigen stimulation. After 5 days of culture, or 3 Medicine Department, National Institute of Health. These days for phytohemagglutinin (PHA) stimulation, each well was healthy blood donors consisted of 76% men; 64% were White, pulsed with 1 µCi of [ 3 H]thymidine, and harvested 18 h 34% Black and 2% Asian. Their ages ranged from 28 to 62 later. Thymidine incorporation was determined using a model LS1801 β-spectrometer (Beckman Instruments, Fullerton, CA). years (mean 40 and median 39). They were randomly chosen All samples were assayed in triplicate and expressed as independent of age, sex or race. 
of cultures in the absence of CMV antigens). If a Isolation of peripheral blood mononuclear cells (PBMC)
sample responded to two out of three CMV antigen preparations (heat-inactivated supernatants of CMV-infected PBMC from each blood sample were separated on lymphocyte fibroblasts, CMV-infected cell lysates or fixed CMV-infected separation medium (Organon Teknika, Durham, NC) by centrifibroblasts) by a stimulation index Ͼ4, the response was fugation at 1800 r.p.m. for 25 min at room temperature. The considered positive. Positive controls included: (i) 3 days of separated cells were collected and washed twice in PBS stimulation with PHA (1:200; Gibco), (ii) influenza A/Bangkok (Gibco, Grand Island, NY). The number of viable cells was RX73 (flu; grown in embryonated eggs and used as infectious determined by Trypan blue exclusion using a hemocytometer.
allantoic fluid at an infectivity of 2ϫ10 4 tissue culture infectious PBMC were then cryopreserved in aliquots in liquid nitrogen dose 50 /well at a final dilution of 1:1000), (iii) Candida antigen until used.
(Greer Laboratories, Lenoir, NC; final dilution of 20 mg/ml), and (iv) a pool of irradiated (5000 rad) PBMC from three Antibody status to CMV unrelated healthy donors (2ϫ10 6 /ml). Negative control Serum collected for the detection of antibodies was frozen included: (i) supernatants, cell lysates and fixed cells from at -80°C. CMV IgG antibodies were determined using an mock-infected fibroblasts prepared exactly as described for ELISA kit (CYTOMEGELISA II; Biowhittaker, Walkersville, MD).
CMV-infected cells, and (ii) RPMI media control. Antibody results were calculated from standard curves proDetection of cytokine production after in vitro antigenic stimuvided by the manufacturer. The threshold value for a 'positive' lation result was determined prospectively: an ELISA value Ͻ0.25 U was considered a negative result and a value of ജ0.25 U Using the same protocol for CMV antigen-induced T lymphocyte proliferation, supernatants of the cultures were collected was considered positive, indicating prior exposure to CMV. of the CMV major immediate early gene (MIE, UL123) and from the CMV late pp150 gene (UL32) were used for PCR. DNA prepared from mock-and CMV-infected HEL299 cells control respectively. Glucose 6-phosphate dehydrogenase Ab ϩ and Ab -: antibody response positive and negative respectively; (G6PD) primer from exons 6 and 7 of the G6PD gene was Tc ϩ and Tc -: T lymphocyte proliferative response positive and negative respectively. used as a control for the presence of DNA or cDNA in each sample. The PCR amplification products were transferred to a nylon membrane by vacuum blotting of the agarose gel and the DNA was cross-linked to a nitrocellulose filter. Hybridat 3 and 6 days after stimulation. Cytokines secreted into the izations with CMV-specific 32 P 3Ј-end-labeled oligonucleotide supernatants of the cell cultures were determined by ELISA.
probes for MIE and pp150 were performed as described The following ELISA kits were used in this study: IFN-γ, IL-2, previously (23). IL-4 and IL-10 (Genzyme, Cambridge, MA). All assays were performed in duplicate according to the manufacturer's Statistical analysis instructions and cytokine levels were calculated by comparData were analyzed by the t-test, χ 2 -test or Fisher's exact ison to standard curves using recombinant cytokines. All test. One degree of freedom χ 2 -tests were used to test the values are given as pg/ml. A change in the level of cytokine independence (lack of trend) of the percentage of individuals was prospectively defined as an increase if it was ജ4 times with increased levels of cytokines from the presence or higher than the control level. The limit for detection of these absence of a positive cellular response to CMV antigen cytokines was in the range of 5-20 pg/ml. stimulation. All tests were two-tailed. P values less than 0.05 were considered significant. CD4 ϩ /CD8 ϩ phenotyping Using the same protocol for CMV antigen-induced T lymphocyte proliferation, we determined whether the proliferative Results response involved CD4 ϩ or CD8 ϩ T cells. The cell phenotype
Patterns of humoral and cellular immune responses to CMV was tested by direct immunofluorescence on a FACScan antigens (Becton Dickinson, San Jose, CA) using 1:10 diluted phycoerythrin-conjugated anti-CD4 ϩ and FITC-conjugated anti-CD8 ϩ To determine whether different individuals have different immunodominant humoral and cellular responses to CMV murine mAb (Becton Dickinson). The percentage of cells with a CD4 ϩ or CD8 ϩ phenotype was tested on day 6 after antigens, blood samples from healthy blood donors were tested for anti-CMV IgG antibodies and for a T lymphocyte exposure to CMV antigens. proliferative response to CMV antigens by [ 3 H]thymidine DNA preparation and PCR analyses uptake. Figure 1 shows the patterns found. Of the 50 individuals, nine (18%) had both anti-CMV IgG antibodies and a DNA preparation and PCR analyses were performed at BioServe (Laurel, MD) by using the methods as described T cell proliferative response to CMV antigens (referred to as the Ab ϩ /Tc ϩ subgroup). Fourteen (28%) who had anti-CMV previously (22,23). DNA was isolated from PBMC samples as well as from mock-infected and CMV-infected human antibodies did not show a CMV-induced T lymphocyte response (referred to as the Ab ϩ /Tc -subgroup). There were fibroblasts (HEL299). Analysis was performed in 30 PBMC samples (12 samples from the Ab -/Tc ϩ group, 14 from the 15 individuals (30%) who were negative for both antibodies and T lymphocyte proliferation to CMV (referred to as the Ab -/Tc -group, two from the Ab ϩ /Tc -group and two from the Ab ϩ /Tc ϩ group). CMV-specific primers from exons 1 and 2
Ab -/Tc -subgroup). Interestingly, 12 (24%) individuals who did To determine whether the CMV-stimulated proliferating cell type mainly belongs to the CD4 ϩ or CD8 ϩ T cell subset, we performed FACS analysis for CD4 ϩ and CD8 ϩ phenotypes of PBMC with and without CMV stimulation in five individuals individuals with a T cell proliferative response to CMV antigens responded with an IL-2 and IFN-γ production (Table 3) . with Ab -/Tc ϩ and five with Ab ϩ /Tc -responses to CMV antigens. Table 1 shows the data derived from these studies.
Increased levels of IL-2 and IFN-γ were not associated with age, gender or race (all P Ͼ 0.05). In contrast, CMV antigens Although the background of CD4 ϩ T cell thymidine incorporation was higher in the Ab -/Tc ϩ group than the Ab ϩ /Tc -group failed to stimulate IL-4 and IL-10 production from PBMC of our study subjects (data not shown). (47.3 versus 28.5%; P ϭ 0.02), the only significant increase of CD4 ϩ T cells after CMV antigen stimulation occurred in Detection of CMV DNA in PBMC the Ab -/Tc ϩ group (P ϭ 0.02). As expected, CMV antigen stimulation did not increase CD8 ϩ T cells expansion under
We did not find CMV DNA in the PBMC of our study population: no major immediate early gene PCR amplification product or the experimental conditions we used.
pp150 PCR product was detected in any of 30 PBMC samples Cellular immune response against CMV characterized by analyzed. However, all controls worked as expected and all production of IL-2/IFN-γ samples amplified a G6PD PCR product except one PBMC sample, indicating adequate quality of template DNA. SouthTo determine whether individuals with a T cell proliferative response to CMV antigens produce an IL-2 and/or IFN-γ ern blot analysis confirmed these PCR results (data not shown). response, we assayed the supernatant of PBMC for IL-2 and IFN-γ production after CMV antigen stimulation. Cytokine levels usually increased within the first 3 days following Discussion exposure to CMV antigens and peaked at day 6. PHA stimulation increased IL-2 and IFN-γ levels regardless of CMV Seroepidemiologic studies have been published demonstrating an association between CMV infection and atherosclerosis seropositivity (data not shown). Table 2 shows that IL-2 and IFN-γ levels increased significantly in response to CMV antigen (14) (15) (16) (17) . However, there are also discordant studies demonstrating no such association (24, 25) . In this context, previous stimulation in individuals within each of the groups that exhibited either a humoral or cellular immune response to studies from our laboratory suggested that inter-individual differences exist in the ability to control CMV-induced inflam-CMV (Ab ϩ /Tc -, Ab -/Tc ϩ and Ab ϩ /Tc ϩ ) at day 6, but did not in individuals without immune responses to CMV antigens matory activity and that such differences appeared to be significant determinants of the prevalence of coronary artery (Ab -/Tc -). However, a significantly greater percentage of disease (26). These findings raised the possibility that indiand IL-10 production. This contrasts to the results found when assaying for IFN-γ and IL-2. The reasons for these findings vidual variation in the immune response to infection may exist and that such differences may determine susceptibility or could be: (i) CMV (Towne strain) antigen may fail to stimulate production of certain cytokines from PBMC of our study resistance to the vasculopathic effects of CMV.
The potential validity of this hypothesis has been reinforced subjects, (ii) the ELISA kits used for IL-4 and IL-10 may be of limited sensitivity or (iii) high-affinity IL-4 and IL-10 receptors by studies relating in cohorts who were exposed to HIV but remained seronegative. It was demonstrated that a subset of may be expressed on peripheral blood mononuclear cells after CMV antigen stimulation to which the cytokines would female sexworkers (1), homosexual men (27) and HIVexposed children (3,4,28) who, despite a high exposure bind and therefore lead to falsely low values. Previous studies suggested that detection of CMV DNA rate to HIV-seropositive individuals, had no evidence of HIV infection and did not seroconvert. Lack of infection was sequences in circulating monocytes by PCR might be a sensitive assay to determine CMV activity (22, 23) . If this were associated with a cell-mediated immune response to HIV antigens in the absence of a specific humoral response (as the case, it would have been interesting to correlate such a finding with immune response phenotype in our cohort. reflected by seronegativity). Similar results were observed in healthy family members of individuals symptomatic with However, we did not find CMV DNA in any of PBMC samples we analyzed. The reasons for the difference between our hepatitis C (19) .
The results of the present investigation provide evidence investigation and previous studies are uncertain. In summary, our results indicate that there is a spectrum of that similar divergences in the humoral versus cellular immune responses to CMV infection may also play a role in resistance humoral versus cellular immune responses to CMV infection in immunocompetent individuals. These findings, when conand susceptibility to CMV-related disease in immunocompetent individuals. We found four immune response subgroups sidered in conjunction with those from the studies discussed above, raise the possibility that there may be an association to CMV antigens in healthy blood donors ( antibody-negative but develop a cell-mediated immune response manifested by secretion of IL-2 by PBMC exposed to certain HIV-1 peptides. In addition, CD4 ϩ cells are essential References for eliminating CMV from certain tissues of virus-infected
